Clinical trial
A Randomized Double Blind Placebo Controlled Trial of Rifapentine and Isoniazid for Prevention of Tuberculosis in People With Diabetes
NCT04600167 is registered in ClinicalTrials.gov with Dr. Nyanda Elias Ntinginya as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blind Placebo Controlled Trial of Rifapentine and Isoniazid for Prevention of Tuberculosis in People With Diabetes
- Lead sponsor
- Dr. Nyanda Elias Ntinginya
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 17, 2022
- Completion date
- December 31, 2025
- Enrollment
- 3,000 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.